The Trial is estimated to cost 35m with 50% competition's valve and 50% ours with a $25k reimbursement and numbers still being negotiated.
By far the biggest take away is the NASDAQ listing aiming for end 2024 with this we should have that re rate rather than this current crap. Lots more as always everyone has the ability to look on line it would make sense to have a look at the presentation when it's uploaded
cheers John.
Ann: AGM Chairman and CEO Presentation, page-7
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |